RecruitingNot ApplicableNCT03775837

Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults

Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults: a Randomized, Double-blinded, Placebo-controlled Trial


Sponsor

Pusan National University Yangsan Hospital

Enrollment

60 participants

Start Date

Dec 1, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Panax Ginseng C.A. Mey Extract on liver function in adults for 8 weeks.


Eligibility

Min Age: 19 YearsMax Age: 75 Years

Inclusion Criteria1

  • ALT ranging from upper limit of reference to three times of upper limit

Exclusion Criteria8

  • Abnormal liver or renal function (i.e., serum aminotransferase activity > 3 times of upper limit of reference range and serum creatinine concentrations > 1.2 mg/dL)
  • Diabetes (diagnosed clinically or fasting glucose level > 126 mg/dL)
  • History of viral hepatitis or cancer
  • Uncontrolled hypertension
  • History of serious cardiac disease such as angina or myocardial infarction
  • History of gastrectomy
  • History of medication for psychiatric disease
  • Administration of oriental medicine including herbs within the past 4 weeks

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTPanax Ginseng C.A. Mey Extract group

This group takes Panax Ginseng C.A. Mey Extract for 8 weeks

DIETARY_SUPPLEMENTPlacebo group

This group takes placebo for 8 weeks


Locations(1)

Integrated Research Institute for Natural Ingredients and Functional Foods

Yangsan, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03775837


Related Trials